Five-year summary year ended 31 March Unaudited 2012 2013 2014 2015 2016 Year ended 31 March m m m m m Consolidated income statement Revenue 33.0 30.5 36.5 58.0 72.0 Gross profit 30.8 29.8 35.5 55.6 68.7 Gross profit margin 93% 98% 97% 96% 95% Research and development expenses 31.7 29.9 26.9 34.9 40.7 Other administrative expenses 3.3 3.3 3.4 4.5 4.8 EBITDA 4.2 3.4 5.2 16.2 23.2 Depreciation of assets 1.1 1.0 1.1 1.2 1.4 Amortisation of intangible assets 7.5 6.3 6.9 20.9 18.8 Non-recurring transaction costs 2.5 5.6 Share-based compensation 1.1 0.9 0.9 1.1 2.5 Operating loss 13.9 11.6 6.2 7.0 5.1 Investment income 0.7 0.5 1.6 0.5 2.7 Finance gains costs 0.7 0.2 1.7 1.1 Share of result of joint venture 1.4 0.6 Loss before taxation 13.2 10.4 4.8 6.2 1.9 Taxation 8.8 4.5 2.5 9.9 6.9 Profit loss after taxation 4.4 5.9 2.3 3.7 5.0 Earnings loss per ordinary share 1.3p 1.8p 0.7p 0.9p 1.2p Cash flow statement Operating loss 13.9 11.6 6.2 7.0 5.1 Depreciation and amortisation 8.6 7.3 8.0 22.1 20.2 Share-based compensation 1.1 0.9 0.9 1.1 2.5 Non-recurring transaction costs paid 2.1 Increase decrease in working capital 2.4 1.1 8.3 13.5 11.2 Decrease increase in deferred income 0.7 3.4 0.4 0.1 0.1 Exchange movements 0.7 0.2 1.8 1.6 Taxation paid Research and development tax credits received 4.6 4.4 4.7 3.6 0.3 Net cash inflow outflow from operations 2.1 2.8 0.7 8.0 32.9 Net capital expenditure 4.2 3.8 2.3 1.4 1.5 Free cash flow inflow outflow 2.1 6.6 3.0 6.6 31.4 Balance sheet Cash and cash equivalents 75.5 70.1 81.7 90.0 99.8 Shareholders equity 139.5 135.1 226.7 221.9 237.2 Net current assets 61.7 60.3 79.4 72.4 95.8 124 Vectura Group plc Annual Report and Accounts 2015 16 SHAREHOLDER INFORMATION Directors Corporate broker Auditor Bruno F J Angelici Peel Hunt LLP Deloitte LLP Non-Executive Chairman Moor House 3 Rivergate 120 London Wall Temple Quay James Ward-Lilley London Bristol Chief Executive Officer EC2Y 5ET, UK BS1 6GD, UK Andrew J Oakley Chief Financial Officer Corporate broker Bankers J. P. Morgan Cazenove Barclays Bank plc Dr Trevor M Phillips 25 Bank Street 28 Chesterton Road Chief Operations Officer and President Canary Wharf Cambridge ofUSOperations London CB4 3AZ, UK Dr John R Brown E14 5JP, UK Non-Executive and Senior Independent Legal advisors Director Registrars Olswang LLP Computershare Investor Services plc 90 High Holborn Dr Susan E Foden PO Box 82 London Non-Executive The Pavilions WC1V 6XX, UK Neil W Warner Bridgwater Road Non-Executive Bristol Legal advisors BS99 7NH, UK Covington & Burling LLP Dr Per-Olof Andersson 265 Strand Non-Executive Public relations London Citigate Dewe Rogerson WC2R 1BH, UK Company Secretary 3 London Wall Buildings Andrew J Oakley London Wall Vectura Group plc London One Prospect West EC2M 5SY, UK Chippenham Wiltshire SN14 6FH, UK Vectura trade marks Adept is a registered trade mark of Innovata Limited AKITA and FAVOLIR are registered trade marks of Vectura GmbH Clickhaler and Duohaler are registered trade marks of Innovata Biomed Limited or Tianjin Kinnovata Pharmaceutical Company Limited Fox is a trade mark of Vectura GmbH GyroHaler and Omnihaler are registered trade marks of Vectura Delivery Devices Limited PowderHale and Vectura are registered trade marks of Vectura Limited Third-party trade marks ADVATE and Extraneal are registered trade marks of Baxter International Inc. Anoro Ellipta, Incruse Ellipta and Relvar Ellipta Breo Ellipta are registered trademarks of GSK AirFluSal, Forspiro, Seebri, Ultibro, Neohaler, Breezhaler andOnbrez are registered trade marks of Novartis AG Utibronis a trade mark of Novartis AG Bluetooth is a trade mark of Bluetooth SIG Forward-looking statement This Annual Report and Accounts contains forward-looking statements, including statements about the discovery, development and commercialisation of products.
Various risks may cause Vecturas actual results to differ materially from those expressed or implied by the forward-looking statements, including: adverse results in clinical development programmes: failure to obtain patent protection for inventions: commercial limitations imposed by patents owned or controlled by third parties: dependence upon strategic alliance partners to develop and commercialise produces and services: difficulties or delays in obtaining regulatory approvals to market products and services resulting from development efforts: the requirement for substantial funding to conduct research and development and to expand commercialisation activities: and product initiatives by competitors.
As a result of these factors, prospective investors are cautioned not to rely on any forward-looking statements.
We disclaim any intention or obligation to update or revise Design Port olio is committed to planting trees or every corporate communications any forward-looking statements, whether as a result of new information, future events or otherwise.
project, in association with Trees or Cities.
Vectura Group plc Annual Report and Accounts 2015 16 Vectura Group plc One Prospect West Chippenham Wiltshire SN14 6FH United Kingdom T 44 0 1249 667700 F 44 0 1249 667701 www.
com Registered in England and Wales Number: 03418970 The Groups commitment to environmental issues is reflected in this Annual Report, which has been printed on FSC certified uncoated Edixion offset.
It was printed in the UK using environmental Waterless printing technology, and vegetable-based inks were used throughout.
Both the manufacturing mill and the printer are registered to the Environmental Management System ISO14001 and are FSC chain-of-custody certified.
